Tumor Suppressor Genes on Human Chromosome 3 and Cancer Pathogenesis

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• The short arm of chromosome 3 (3p) is frequently altered in various human cancers.
• Specific 3p regions are implicated in tumorigenesis, with deletions observed in cancer cells and tissues.
• Tumorigenicity can increase with 3p region elimination in microcell hybrids.

Purpose of the Study:

• To analyze chromosome instability and key tumor pathogenesis genes (VHL, RIITGFB, CATNB, MLH1, FHIT) on chromosome 3p across eleven tumor types.
• To investigate the tissue-specific importance of the common eliminated region 1 (CER1).
• To compare the frequency of losses for VHL, FHIT/FRA3B, and CER1 in human tumors.

Main Methods:

• Deletion studies in human cancer cells and tissues.
• Analysis of microcell hybrids and tumorigenicity in immunosuppressed mice.
• Comparative analysis of gene alterations (VHL, FHIT, CER1) across eleven tumor types.

Main Results:

• The importance of the common eliminated region 1 (CER1) transcends tissue specificity.
• The CER1 region is preferentially lost in human tumors compared to VHL and FHIT/FRA3B.
• FHIT gene alterations are linked to reduced survival in breast and colon cancer patients.
• Chromosome 3 instability, especially involving FHIT, is observed in breast cancer patients with BRCA2 germline mutations.

Conclusions:

• Results indicate a synergism of tumor suppressor gene (TSG) losses on chromosome 3p.
• These losses correlate with the biological behavior and pathogenesis of tumor cells.
• Chromosome instability in BRCA2-associated tumors reflects impaired DNA repair mechanisms.